1. Home
  2. PODD vs CNP Comparison

PODD vs CNP Comparison

Compare PODD & CNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • CNP
  • Stock Information
  • Founded
  • PODD 2000
  • CNP 1866
  • Country
  • PODD United States
  • CNP United States
  • Employees
  • PODD N/A
  • CNP N/A
  • Industry
  • PODD Medical/Dental Instruments
  • CNP Electric Utilities: Central
  • Sector
  • PODD Health Care
  • CNP Utilities
  • Exchange
  • PODD Nasdaq
  • CNP Nasdaq
  • Market Cap
  • PODD 21.5B
  • CNP 24.0B
  • IPO Year
  • PODD 2007
  • CNP N/A
  • Fundamental
  • Price
  • PODD $292.01
  • CNP $36.21
  • Analyst Decision
  • PODD Strong Buy
  • CNP Buy
  • Analyst Count
  • PODD 19
  • CNP 13
  • Target Price
  • PODD $320.11
  • CNP $35.96
  • AVG Volume (30 Days)
  • PODD 753.8K
  • CNP 4.8M
  • Earning Date
  • PODD 08-07-2025
  • CNP 07-24-2025
  • Dividend Yield
  • PODD N/A
  • CNP 2.43%
  • EPS Growth
  • PODD 67.46
  • CNP 3.75
  • EPS
  • PODD 5.55
  • CNP 1.48
  • Revenue
  • PODD $2,198,900,000.00
  • CNP $8,943,000,000.00
  • Revenue This Year
  • PODD $24.49
  • CNP $8.98
  • Revenue Next Year
  • PODD $17.45
  • CNP $4.00
  • P/E Ratio
  • PODD $52.60
  • CNP $24.37
  • Revenue Growth
  • PODD 23.48
  • CNP 4.76
  • 52 Week Low
  • PODD $173.00
  • CNP $25.41
  • 52 Week High
  • PODD $329.33
  • CNP $39.31
  • Technical
  • Relative Strength Index (RSI)
  • PODD 38.75
  • CNP 47.88
  • Support Level
  • PODD $289.03
  • CNP $35.82
  • Resistance Level
  • PODD $300.00
  • CNP $36.25
  • Average True Range (ATR)
  • PODD 7.17
  • CNP 0.52
  • MACD
  • PODD -1.98
  • CNP 0.04
  • Stochastic Oscillator
  • PODD 11.05
  • CNP 55.97

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.

About CNP CenterPoint Energy Inc (Holding Co)

CenterPoint Energy owns a portfolio of businesses. Its regulated electric utilities provide transmission and distribution services to more than 2.5 million customers in the Houston area, southern Indiana, and west central Ohio. The company has natural gas distribution systems serving approximately 4 million customers.

Share on Social Networks: